// App-Quantinova.ai

: Perampanel as Early Add-on Therapy for Epilepsy Patients with Focal and Generalized Seizures Treated in Clinical Practice

Researchers

Presenter

  • Estevo Santamarina

Principal Investigators

  • Javier Abril-Jaramillo

  • Xiana Rodriguez-Osorio

  • Takamichi Yamamoto

  • Rob McMurray

  • Eugen Trinka

  • Wendyl DSouza

  • Vicente Villanueva

Medical Centers

  • Epilepsy Unit, Neurology Department, Vall d’Hebron University Hospital, Barcelona, Spain

  • Centro de Neurología Avanzada, Sevilla, Spain

  • Department of Neurology, Complexo Hospitalario Universitario de Santiago, Santiago, Spain

  • Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Shizuoka, Japan

  • European Knowledge Centre, Eisai Europe Ltd, Hatfield, Hertfordshire, UK

  • Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Salzburg, Austria

  • Department of Medicine St Vincent's Hospital, University of Melbourne, Fitzroy, Australia

  • Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Locations

  • Spain

  • Japan

  • United Kingdom

  • Austria

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Epilepsy

Biomarkers

  • N/A

Drug/Treatment

  • Perampanel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved